Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.78 |
| ▸ | EYA2 | O00167 | 1/20 | 0.78 |
| ▸ | APP | P05067 | 1/20 | 0.78 |
| ▸ | ACE | P12821 | 1/20 | 0.78 |
| ▸ | BLM | P54132 | 2/20 | 0.74 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.74 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.74 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | DRD1 | P21728 | 1/20 | 0.74 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.74 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.74 |
| ▸ | DRD3 | P35462 | 1/20 | 0.74 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.74 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL6830888 | 0.97 | TDP1 (0.74) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6830896 | 0.97 | TDP1 (0.74) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL9695792 | 0.95 | TDP1 (0.70) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL12492986 | 0.91 | TDP1 (0.64) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL891596 | 0.89 | TDP1 (0.78) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL6840078 | 0.89 | TDP1 (0.78) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1318987 | 0.89 | TDP1 (0.78) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL357531 | 0.89 | TDP1 (0.78) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL9685534 | 0.89 | TDP1 (0.78) | TDP1EYA2APPACEBLM | |
| Nitrilotriacetic Acid SCHEMBL4015790 | 0.88 | GLRA1 (0.62) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8980122-B2 | Contact release capsule useful for chemical mechanical planarization slurry | GENERAL ENGINEERING & RESEARCH, L.L.C. (US) | 2015-03-17 | — | — | US | claimed |
| EP-2814981-A2 | BLOOD COLLECTION DEVICE FOR STABILIZING CELL-FREE PLASMA DNA | Streck Inc. (US) | 2014-12-24 | — | — | EP | claimed |
| WO-2013123030-A2 | BLOOD COLLECTION DEVICE FOR IMPROVED NUCLEIC ACID REGULATION | STRECK, INC. (US) | 2013-08-22 | — | — | WO | claimed |
| US-9605038-B2 | Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis | Kyungpook National University Industry—Academic Cooperation Foundation (KR) | 2017-03-28 | — | — | US | disclosed |
| EP-2646473-B1 | FUSION PEPTIDE COMPRISING DHFAS-1 DOMAIN AND MMP SUBSTRATE AND USE THEREOF FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | KYUNGPOOK NAT UNIV INDUSTRY- ACAD COOP FOUND (KR) | 2017-02-15 | — | — | EP | disclosed |
| CN-103370340-B | Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis | 庆北大学校产学协力团 | 2016-08-31 | — | — | CN | disclosed |
| US-20140147453-A1 | FUSION PEPTIDE COMPRISING dhFas-1 DOMAIN AND MMP SUBSTRATE AND USE THEREOF FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2014-05-29 | — | — | US | disclosed |
| CN-103370340-A | Fusion peptide comprising dhFas-1 domain and MMP substrate and use thereof for preventing and treating rheumatoid arthritis | KYUNGPOOK NAT UNIV IND ACAD | 2013-10-23 | — | — | CN | disclosed |
| EP-2646473-A2 | FUSION PEPTIDE COMPRISING DHFAS-1 DOMAIN AND MMP SUBSTRATE AND USE THEREOF FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | Kyungpook National University Industry- Academic Cooperation Foundation (KR) | 2013-10-09 | — | — | EP | disclosed |
| WO-2012074330-A2 | FUSION PEPTIDE COMPRISING DHFAS-1 DOMAIN AND MMP SUBSTRATE AND USE THEREOF FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2012-06-07 | — | — | WO | disclosed |
| US-6743434-B1 | COMPOSITION SUITABLE FOR CONDITIONING KERATINOUS SUBSTRATE COMPRISING PANTHENOL, CITRIC ACID, WATER, AND WATER SOLUBLE SOURCE OF BICARBONATE; LIQUID CRYSTAL | LUNDMARK LARRY D (US) | 2004-06-01 | — | — | US | disclosed |
| US-6365143-B1 | MIXTURE OF AN AMINOACETIC ACID, ETHYLENEDIAMINETETRAACETIC ACID, CITRIC ACID AND WATER | LUNDMARK LARRY D (US) | 2002-04-02 | — | — | US | disclosed |
| US-5976344-A | A FIRST LIGAND OPERATES TO FORM A COMPLEX OF PALLADIUM AND A SECOND LIGAND FUNCTIONS TO FORM A COMPLEX OF ANOTHER METAL WHICH BRINGS THE PLATING POTENTIALS OF THE TWO METALS CLOSER TOGETHER. PALLADIUM AND THE ALLOYING METAL THUS EXIST AS | LUCENT TECHNOLOGIES INC. (US) | 1999-11-02 | — | — | US | disclosed |
| US-3963578-A | ASPARTATE, ETHYLENEDIAMINETETRAACETIC ACID, AMMONIUM SULFATE, SODIUM PHOSPHATE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-15 | — | — | US | disclosed |